Kiniksa
Kiniksa Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...
Nektar Therapeutics (NKTR) Shareholder/Analyst Call - Slideshow
Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways
Nuvectis Pharma, Inc. (NVCT) Q3 2026 Earnings Call Transcript
Tenon Medical, Inc. (TNON) Q3 2026 Earnings Call Prepared Remarks Transcript
Travere (TVTX) Q3 2026 Earnings Call Transcript
FILSPARI sales hit $200.2 million as FSGS launches alongside sustained IgAN demand.
Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma Transcript
Lineage Cell Therapeutics, Inc. (LCTX) Q3 2026 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation...
Axonics
Axonics Anonymous (not verified) Mon, 11/16/2026 - 00:40 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
XNTK: An Equally Weighted And Narrow Universe Of High-Growth Technology Stocks
Seastar Medical anticipates NEUTRALIZE-AKI enrollment completion by midyear 2027 while preparing modular PMA submissions
Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment
Torex Resources Inc. (TXR:CA) Q3 2026 Earnings Call Transcript
Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln
Hexis Capital Moving Nicotine Fund to TXSE - Tobacco Reporter
Hexis Capital Moving Nicotine Fund to TXSE - Tobacco Reporter
NPK International Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into NPK Intern...
NPK International lowered its full-year 2026 revenue and Adjusted EBITDA guidance, citing adverse Texas weather that delayed expected matting deployments on large-scale projects. L...
Major earnings expected before the bell on Tuesday include:
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.